CPIX (Cumberland Pharmaceuticals) Shiller PE Ratio: (As of Aug. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CPIX Cumberland Pharmaceuticals Inc CPIX
36 GF Score
Price $7.79
GF Value $2.41
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Cumberland Pharmaceuticals Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Cumberland Pharmaceuticals  (NAS:CPIX) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Cumberland Pharmaceuticals Shiller PE Ratio Related Terms


Cumberland Pharmaceuticals Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for Cumberland Pharmaceuticals's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cumberland Pharmaceuticals Shiller PE Ratio Chart

Cumberland Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Cumberland Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CPIX vs BGM, ZYBT, TLPH: Shiller PE Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cumberland Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cumberland Pharmaceuticals Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cumberland Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Cumberland Pharmaceuticals's Shiller PE Ratio falls into.


CPIX
36GF Score
Cumberland Pharmaceuticals Inc CPIX
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cumberland Pharmaceuticals Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Cumberland Pharmaceuticals's E10 for the quarter that ended in Jun. 2026 is calculated as:

For example, Cumberland Pharmaceuticals's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.29/333.9520*333.9520
=-0.290

Current CPI (Jun. 2026) = 333.9520.

Cumberland Pharmaceuticals Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201609 0.010 241.428 0.014
201612 -0.050 241.432 -0.069
201703 -0.080 243.801 -0.110
201706 -0.320 244.955 -0.436
201709 -0.050 246.819 -0.068
201712 -0.050 246.524 -0.068
201803 -0.150 249.554 -0.201
201806 -0.050 251.989 -0.066
201809 -0.110 252.439 -0.146
201812 -0.140 251.233 -0.186
201903 0.000 254.202 0.000
201906 -0.040 256.143 -0.052
201909 -0.130 256.759 -0.169
201912 -0.060 256.974 -0.078
202003 -0.070 258.115 -0.091
202006 -0.060 257.797 -0.078
202009 -0.030 260.280 -0.038
202012 -0.060 260.474 -0.077
202103 0.010 264.877 0.013
202106 0.080 271.696 0.098
202109 -0.070 274.310 -0.085
202112 -0.260 278.802 -0.311
202203 -0.090 287.504 -0.105
202206 -0.090 296.311 -0.101
202209 -0.030 296.808 -0.034
202212 -0.170 296.797 -0.191
202303 0.010 301.836 0.011
202306 0.060 305.109 0.066
202309 -0.070 307.789 -0.076
202312 -0.440 306.746 -0.479
202403 -0.140 312.332 -0.150
202406 -0.080 314.175 -0.085
202409 -0.110 315.301 -0.117
202412 -0.140 315.605 -0.148
202503 0.080 319.799 0.084
202506 -0.050 322.561 -0.052
202509 -0.130 324.800 -0.134
202512 -0.090 324.054 -0.093
202603 -0.220 330.213 -0.222
202606 -0.290 333.952 -0.290

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Cumberland Pharmaceuticals (CPIX) Overvalued in 2026?

Based on GuruFocus' analysis, Cumberland Pharmaceuticals stock appears to be overvalued. The current stock price of $7.79 is trading 223.2% above its estimated GF Value™ of $2.41. GuruFocus considers Cumberland Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for CPIX:

  • Shiller PE Ratio:
  • GF Value™: $2.41 vs. price of $7.79 (223.2% above fair value)
  • GF Score™: 36/100 with 5 warning signs

No single metric tells the full story. See the CPIX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cumberland Pharmaceuticals Business Description

Address 1600 West End Avenue, Suite 1300, Nashville, TN, USA, 37203
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.
36GF Score

Get the complete analysis for CPIX

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.79
Price
$2.41
GF Value